Vesalius Biocapital Partners Sàrl

Overview

Vesalius Biocapital Partners Sàrl is a Luxembourg-based venture capital firm specializing in European life sciences investments. Since its inception in 2007, the firm has raised over €260 million across three funds and contributed to the development of more than 30 companies. The team comprises seasoned life science professionals with backgrounds in healthcare industry, corporate finance, and strategy consulting, supporting companies through their growth cycle. Vesalius Biocapital III, launched in April 2017, announced a final close with €120 million in commitments in 2019. The fund targets later-stage European life science companies in drug development, medical devices, diagnostics, and digital health. The firm's investment strategy focuses on three areas: therapeutics, medical devices, and diagnostics. Vesalius Biocapital Partners plays the role of lead investor in the majority of its financing rounds and is actively involved in the development of its portfolio companies. The firm is based in Europe, allowing for easy interaction with management teams and a deep understanding of the European market. Vesalius Biocapital Partners invests in all stages of development and is open to relatively early-stage projects with sound proprietary technology, unique team skills, and a clear competitive edge based on solid data. The firm has contributed to the development of over 20 companies since its inception, with more than €150 million under management in two funds. Vesalius Biocapital Partners is committed to supporting innovative life science companies in Europe and plays an active role in their growth and success.

Investment Focus

• Sound proprietary technology
• Unique team skills
• Clear competitive edge based on solid data

Portfolio Companies